Allermi
Personalized allergy care, delivered.
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2C
- Website
- allermi.com
- Total Funding
- $4.8M
- Last Round
- $3.5M SeedMar 2023
About
Allermi is a telehealth company offering personalized prescription allergy nasal sprays compounded by pharmacists based on each patient's specific allergy profile. Founded by Stanford-trained allergists, Allermi replaces generic OTC allergy medications with evidence-based, custom-formulated sprays delivered directly to patients. The platform combines an online allergy assessment, physician review, and subscription-based delivery of custom treatments.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account